510(k) Report

510(k) · Cleared

Cleared

Avaulta Support System

K082571510(k) SpecialCleared Sep 30, 200825-day reviewClass III21 CFR 884.5980

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

C.R. Bard, Inc. · OTP Mesh, Surgical, Synthetic, Urogynecologic, For Pelvic Organ Prolapse, Transvaginally Placed

Cleared on Sep 30, 2008 as substantially equivalent to K063712 (C.R. Bard, Inc., 2007) after a 25-day review. Its family tree reaches back 4 generations to 1999. 1 later device descends from it.

Decided
Sep 30, 2008
Review
25 days
Class
Class III
Product code
OTP
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K991400 (1999). 7 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2002: 1 other ancestor2001: 1 other ancestor2009: 1 descendant clearedK991400 · Parietene Polypropylene Mesh · Sofradim Production · 1999K033376 · Ugytex Mesh · Sofradim Production · 2004K051503 · Ugytex Sual Knit Mesh · Sofradim Production · 2005K063712 · Avaulta Support System/Avaulta Plus Biosynthetic Support System · C.R. Bard, Inc. · 20071995200020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor4 generations back: 2 other ancestors 1 generation forward: 1 descendant K063712 · Avaulta Support System/Avaulta Plus Biosynthetic Support System · C.R. Bard, Inc. · 2007K051503 · Ugytex Sual Knit Mesh · Sofradim Production · 2005K033376 · Ugytex Mesh · Sofradim Production · 2004K991400 · Parietene Polypropylene Mesh · Sofradim Production · 19990
  1. Root · 4 generations backK991400 Parietene Polypropylene MeshSofradim Production · 1999
  2. 3 generations backK033376 Ugytex MeshSofradim Production · 2004
  3. 2 generations backK051503 Ugytex Sual Knit MeshSofradim Production · 2005
  4. 1 generation backK063712 Avaulta Support System/Avaulta Plus Biosynthetic Support SystemC.R. Bard, Inc. · 2007
  5. This deviceK082571 Avaulta Support SystemC.R. Bard, Inc. · 2008
  6. Descendant · cites it directly · 0 of its ownK083839 Avaulta Solo Synthetic Support System, Avaulta Plus Biosynthetic…C.R. Bard, Inc. · 2009

Most influential descendants

Showing 1 of 1 · See all
  • K083839Avaulta Solo Synthetic Support System, Avaulta Plus Biosynthetic Support SystemC.R. Bard, Inc. · 2009 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K991400Parietene Polypropylene MeshSofradim Production1999—
−3K033376Ugytex MeshSofradim Production2004—
−2K051503Ugytex Sual Knit MeshSofradim Production2005—
−1K063712Avaulta Support System/Avaulta Plus Biosynthetic Support SystemC.R. Bard, Inc.2007—
0 (this device)K082571Avaulta Support SystemC.R. Bard, Inc.2008—
+1K083839Avaulta Solo Synthetic Support System, Avaulta Plus Biosynthetic Support SystemC.R. Bard, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200210
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
FIG. 1 — Lineage of K082571, 1999–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OTP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K063712Avaulta Support System/Avaulta Plus Biosynthetic Support System
Summary page 1
…78.3300 Classification Panel: General and Plastic Surgery C. PREDICATE DEVICE NAME: Trade Names: Avaulta™ Solo Support System Avaulta™ Plus Biosynthetic Support System K063712 D. DeVICE DESCRIPTION: The Avaulta™ Support System includes a sterile, single use, permanent implant that provides long term rei…
C.R. Bard, Inc.2007—

Also cleared against K063712: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K083839Avaulta Solo Synthetic Support System, Avaulta Plus Biosynthetic Support SystemC.R. Bard, Inc.20090

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 2 companies; a new generation was cleared every 1.6 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • Of its descendants, K083839 (C.R. Bard, Inc., 2009) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K063712.

How does its category compare?

All OTP devices

OTP Mesh, Surgical, Synthetic, Urogynecologic, For Pelvic Organ Prolapse, Transvaginally Placed: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · OTP

2in 2012

2007: 42008: 82009: 62011: 52012: 2
2007high 8 (2008) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OTP

71in 2011

2007: 90 days median2008: 103 days median2009: 21 days median2011: 71 days median
2007high 103 (2008) · low 21 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OTP

No recall names OTP since 2007.

Adverse event reports per year · OTP

26in 2025

2007: 12009: 32010: 32011: 322012: 4942013: 7,1502014: 7782015: 6842016: 4152017: 2732018: 3922019: 3682020: 1752021: 6472022: 1142023: 592024: 352025: 26
2007high 7,150 (2013) · low 0 (2008)2025

MAUDE reports naming product code OTP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200749001
2008810300
200962103
20100—03
2011571032
20122—0494
20130—07,150
20140—0778
20150—0684
20160—0415
20170—0273
20180—0392
20190—0368
20200—0175
20210—0647
20220—0114
20230—059
20240—035
20250—026
20260—0—

What is it indicated for?

The Avaulta™ Support System is indicated for tissue reinforcement and long-lasting stabilization of fascial structures of the pelvic floor in vaginal wall prolapse where surgical treatment is intended either as mechanical support or bridging material for the fascial defect.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K082571: Avaulta Support System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K082571

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026